In an Alzheimer’s disease rodent model, Diminazene, an ACE2 activator was found to increase CREB, BDNF, and nicotinic receptors while reducing apoptotic and inflammatory proteins which all play a major role in adult neurogenesis (Kamel et al., 2018). Here, BDNF is linked to early-onset autosomal dominant Alzheimer disease.